Cabazitaxel followed by androgen deprivation therapy (ADT) significantly improves time to progression in patients with newly diagnosed metastatic hormone sensitive prostate cancer (mHSPC) : A randomized, open label, phase III, multicenter trial

Andrén, Ove, 1963- (author)

Örebro universitet,Institutionen för medicinska vetenskaper,Department of Urology, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden

Widmark, A. (author)

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

Fält, A. (author)

Clinical Epidemiology and Biostatistics

show more...

Ulvskog, E., 1963- (author)

Örebro universitet,Institutionen för medicinska vetenskaper,Department of Oncology, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden

Davidsson, Sabina, 1972- (author)

Örebro universitet,Institutionen för medicinska vetenskaper,Department of Urology, Faculty of Health and Medical Sciences, Örebro University, Örebro, Sweden

Karlsson, C. Thellenberg (author)

Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden

Hjälm-Eriksson, M. (author)

Department of Oncology, Karolinska Institute, Stockholm, Sweden

show less...

 (creator_code:org_t)

Oxford University Press, 2017

2017

English.

In: Annals of Oncology. - : Oxford University Press. - 0923-7534 .- 1569-8041. ; 28:Suppl. 5

Related links:

https://urn.kb.se/re...

show more...

http://kipublication...

show less...

• Journal article (other academic/artistic)